|
hepatocellular carcinoma |
31 |
|
humans |
19 |
|
liver cancer |
17 |
|
asian continental ancestry group - genetics |
15 |
|
cell line, tumor |
15 |
|
genetic predisposition to disease |
15 |
|
genome-wide association study |
15 |
|
reverse transcriptase polymerase chain reaction |
13 |
|
ephrin-a2 - genetics |
12 |
|
lupus erythematosus, systemic - genetics |
12 |
|
peptidyl-prolyl-isomerase |
12 |
|
pin1 |
12 |
|
transfection |
12 |
|
beta catenin |
11 |
|
carcinoma, hepatocellular - etiology - genetics - metabolism |
11 |
|
cyclin d1 - biosynthesis - genetics |
11 |
|
cytoskeletal proteins - genetics |
11 |
|
peptidylprolyl isomerase - biosynthesis - genetics |
11 |
|
trans-activators - genetics |
11 |
|
β-catenin |
11 |
|
female |
10 |
|
gene mutation |
10 |
|
hepatitis b |
10 |
|
intracellular signaling peptides and proteins - genetics |
10 |
|
lupus erythematosus, systemic - enzymology - genetics |
10 |
|
animals |
9 |
|
carcinoma, hepatocellular - metabolism |
9 |
|
gene expression regulation, neoplastic |
9 |
|
liver neoplasms - metabolism |
9 |
|
mice |
9 |
|
adult |
8 |
|
aged |
8 |
|
cell proliferation |
8 |
|
cyclin a2 |
8 |
|
epigenesis, genetic |
8 |
|
hbv integration |
8 |
|
male |
8 |
|
middle aged |
8 |
|
next-generation sequencing |
8 |
|
rsk2 |
8 |
|
splicing |
8 |
|
actins - metabolism |
7 |
|
amino acid sequence |
7 |
|
cell movement |
7 |
|
mutation screening |
7 |
|
neoplasm invasiveness |
7 |
|
rna, messenger - metabolism |
7 |
|
tumor suppressor proteins - genetics - metabolism |
7 |
|
aged, 80 and over |
6 |
|
animal experiment |
6 |
|
animal model |
6 |
|
autoclave |
6 |
|
cardiac myosins - metabolism |
6 |
|
chromosome 8p |
6 |
|
data mining |
6 |
|
dextran coated magnetic nanoparticle |
6 |
|
dna methylation |
6 |
|
epigenetics |
6 |
|
filtration; sterilization |
6 |
|
gene silencing |
6 |
|
genetic association |
6 |
|
hcc |
6 |
|
liver - pathology |
6 |
|
liver carcinogenesis |
6 |
|
molecular sequence data |
6 |
|
myosin light chains - metabolism |
6 |
|
neoplasm metastasis |
6 |
|
prognosis |
6 |
|
ros |
6 |
|
uv irradiation |
6 |
|
3t3 cells |
5 |
|
apoptosis |
5 |
|
base sequence |
5 |
|
biosensing platforms |
5 |
|
cancer biomarker |
5 |
|
carcinoma, hepatocellular - enzymology - genetics - pathology |
5 |
|
carcinoma, hepatocellular - genetics |
5 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
5 |
|
carcinoma, hepatocellular - metabolism - mortality - secondary |
5 |
|
cell adhesion - physiology |
5 |
|
cell shape |
5 |
|
cell transformation, neoplastic |
5 |
|
clinical diagnostics |
5 |
|
concentration ratio |
5 |
|
controlled study |
5 |
|
deleted in liver cancer 1 |
5 |
|
enzyme activation |
5 |
|
experimental data |
5 |
|
fibroblasts - cytology - physiology |
5 |
|
gene expression regulation, neoplastic - genetics |
5 |
|
gene knockdown techniques |
5 |
|
genes, tumor suppressor |
5 |
|
gtpase-activating proteins |
5 |
|
gtpase-activating proteins - genetics - metabolism |
5 |
|
hepatic tumors |
5 |
|
immunotherapy |
5 |
|
isoforms |
5 |
|
liver neoplasms - enzymology - genetics - pathology |
5 |
|
liver neoplasms - genetics |
5 |
|
liver neoplasms - genetics - metabolism - pathology |
5 |
|
liver neoplasms - metabolism - mortality - pathology |
5 |
|
loss of heterozygosity |
5 |
|
micrornas - metabolism |
5 |
|
molecular pathogenesis |
5 |
|
non-coding rna |
5 |
|
protein isoforms |
5 |
|
protein isoforms - genetics - metabolism |
5 |
|
rho-associated kinases - analysis - metabolism |
5 |
|
rhoa gtp-binding protein - antagonists & inhibitors - metabolism |
5 |
|
transcription, genetic |
5 |
|
tumor progression |
5 |
|
tumor stem cell assay |
5 |
|
young adult |
5 |
|
animal |
4 |
|
azacitidine - analogs & derivatives - pharmacology |
4 |
|
bagg albino mouse |
4 |
|
beta catenin - metabolism |
4 |
|
blotting, western |
4 |
|
breast neoplasms - pathology |
4 |
|
c57bl mouse |
4 |
|
carcinoma, hepatocellular - enzymology - pathology |
4 |
|
carcinoma, hepatocellular - genetics - metabolism |
4 |
|
carcinoma, hepatocellular - metabolism - pathology |
4 |
|
cdc42 gtp-binding protein - metabolism |
4 |
|
cell hypoxia |
4 |
|
cell nucleus - metabolism |
4 |
|
cell survival |
4 |
|
chromatin assembly and disassembly |
4 |
|
chromosomes, human, pair 13 |
4 |
|
clustered regularly interspaced short palindromic repeat |
4 |
|
collagen - metabolism |
4 |
|
cpg islands - genetics |
4 |
|
crispr library screening |
4 |
|
cytoplasm - metabolism |
4 |
|
dna - chemistry |
4 |
|
dna, complementary - metabolism |
4 |
|
drug-resistance |
4 |
|
extracellular matrix |
4 |
|
gata |
4 |
|
genes, reporter |
4 |
|
genes, tumor suppressor - physiology |
4 |
|
genetic alterations |
4 |
|
genetic transfection |
4 |
|
glycoproteins - genetics |
4 |
|
golgi apparatus - physiology |
4 |
|
gtpase-activating proteins - chemistry - genetics - physiology |
4 |
|
gtpase-activating proteins - genetics |
4 |
|
hypoxia |
4 |
|
hypoxia-inducible factor 1 - genetics - physiology |
4 |
|
immune regulation |
4 |
|
liver - metabolism |
4 |
|
liver neoplasms - enzymology - pathology |
4 |
|
liver neoplasms - genetics - metabolism |
4 |
|
liver neoplasms - metabolism - pathology |
4 |
|
luciferases - metabolism |
4 |
|
lung metastasis |
4 |
|
metabolism |
4 |
|
mice, inbred balb c |
4 |
|
mice, nude |
4 |
|
micro-rna |
4 |
|
mir-874-3p |
4 |
|
mitochondria |
4 |
|
mouse model |
4 |
|
mutation - genetics |
4 |
|
myosin-light-chain phosphatase - metabolism |
4 |
|
nf-kappa b - biosynthesis |
4 |
|
phosphorylation |
4 |
|
plasmids - metabolism |
4 |
|
polymerase chain reaction |
4 |
|
pseudopodia - metabolism |
4 |
|
rac1 gtp-binding protein - metabolism |
4 |
|
ras proteins - metabolism |
4 |
|
reprogramming |
4 |
|
rho gtpase |
4 |
|
rho-associated kinase |
4 |
|
rho-associated kinases - metabolism |
4 |
|
rhoa gtp-binding protein - metabolism |
4 |
|
rna - metabolism |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
signal transduction |
4 |
|
stress fibers - metabolism |
4 |
|
time factors |
4 |
|
trans-activators - biosynthesis |
4 |
|
transcription factors - analysis - classification - metabolism - physiology |
4 |
|
tumor suppressor proteins - genetics - physiology |
4 |
|
tumor suppressor proteins - metabolism - physiology |
4 |
|
up-regulation |
4 |
|
urokinase-type plasminogen activator - biosynthesis |
4 |
|
wnt proteins - metabolism |
4 |
|
adaptor proteins, signal transducing |
3 |
|
alleles |
3 |
|
alternative splicing |
3 |
|
cancer |
3 |
|
cancer metabolism |
3 |
|
cancer metastasis |
3 |
|
cancer therapy |
3 |
|
carcinoma, hepatocellular - genetics - metabolism - mortality - pathology |
3 |
|
carcinoma, hepatocellular - genetics - mortality - pathology - secondary |
3 |
|
carcinoma, hepatocellular - genetics - pathology |
3 |
|
carcinoma, hepatocellular - genetics - physiopathology |
3 |
|
cell differentiation |
3 |
|
chromosome aberrations |
3 |
|
chromosome deletion |
3 |
|
chromosomes, human, pair 13 - genetics |
3 |
|
clinicopathologic correlation and prognostication |
3 |
|
cytokeratin 19 |
3 |
|
cytoskeletal proteins - antagonists & inhibitors |
3 |
|
cytoskeletal proteins - biosynthesis - genetics |
3 |
|
cytoskeletal reorganization |
3 |
|
dapper |
3 |
|
demethylation |
3 |
|
dna - analysis |
3 |
|
dna mutational analysis |
3 |
|
dna, neoplasm - metabolism |
3 |
|
down-regulation |
3 |
|
fact complex |
3 |
|
g9a |
3 |
|
gastrointestinal cancer |
3 |
|
gene amplification |
3 |
|
genetic markers - genetics |
3 |
|
hai-2 |
3 |
|
hbv-associated multistep |
3 |
|
hdpr1 |
3 |
|
hepatitis b - complications |
3 |
|
hepatitis b antigens - metabolism |
3 |
|
hepatitis b virus |
3 |
|
hepatocarcinogenesis |
3 |
|
histone h3 |
3 |
|
histone modifications |
3 |
|
hottip |
3 |
|
hydrodynamic tail vein injection |
3 |
|
igf2bp3 |
3 |
|
immunogenic cell death |
3 |
|
intercellular signaling peptides and proteins - physiology |
3 |
|
intracellular signaling peptides and proteins - metabolism |
3 |
|
jnk signaling |
3 |
|
kunitz domain |
3 |
|
lipid peroxidation |
3 |
|
liver diseases - genetics - pathology |
3 |
|
liver neoplasms - genetics - metabolism - mortality - pathology |
3 |
|
liver neoplasms - genetics - mortality - pathology |
3 |
|
liver neoplasms - genetics - pathology |
3 |
|
liver neoplasms - genetics - physiopathology |
3 |
|
lncrna |
3 |
|
m6a |
3 |
|
m6a modification |
3 |
|
membrane glycoproteins - genetics - metabolism |
3 |
|
metastasis |
3 |
|
mettl3 |
3 |
|
mice, knockout |
3 |
|
microrna |
3 |
|
microrna expression |
3 |
|
micrornas - genetics - metabolism |
3 |
|
microsatellite repeats |
3 |
|
mir-1 |
3 |
|
mir-125b |
3 |
|
mir-200 family |
3 |
|
mirna |
3 |
|
mutation |
3 |
|
mutations |
3 |
|
nuclear accumulation |
3 |
|
nuclear proteins - genetics - physiology |
3 |
|
overexpression |
3 |
|
p-glycoproteins - genetics |
3 |
|
phosphatidylinositol 3-kinases - metabolism |
3 |
|
polymorphism, single nucleotide |
3 |
|
ppp |
3 |
|
preclinical models |
3 |
|
promoter regions, genetic |
3 |
|
protein structure, tertiary |
3 |
|
protein-serine-threonine kinases - metabolism |
3 |
|
protein-tyrosine kinases - antagonists & inhibitors |
3 |
|
proto-oncogene proteins c-akt - metabolism |
3 |
|
rarres3 |
3 |
|
regulated cell death |
3 |
|
rho |
3 |
|
rho gtp-binding proteins - metabolism |
3 |
|
rho/rock signaling pathway |
3 |
|
rna, neoplasm - genetics |
3 |
|
rock |
3 |
|
sequence homology, amino acid |
3 |
|
serine protease inhibitor |
3 |
|
signal transduction - genetics - physiology |
3 |
|
signal transduction - physiology |
3 |
|
signaling pathways |
3 |
|
ssp pathway |
3 |
|
ssrp1 |
3 |
|
stm2457 |
3 |
|
supt16h |
3 |
|
survival analysis |
3 |
|
tki treatment |
3 |
|
tkt |
3 |
|
tor serine-threonine kinases |
3 |
|
trans-activators |
3 |
|
trans-activators - antagonists & inhibitors |
3 |
|
tumor markers, biological - biosynthesis - genetics |
3 |
|
vascular neoplasms - genetics - mortality - secondary |
3 |
|
wnt proteins |
3 |
|
wnt/β-catenin signaling |
3 |
|
antioncogenes. |
2 |
|
cancer epigenetics |
2 |
|
carcinogenesis |
2 |
|
carcinoma, hepatocellular - genetics - virology |
2 |
|
cell biology |
2 |
|
cell cycle - drug effects |
2 |
|
cell division - drug effects |
2 |
|
cell migration |
2 |
|
cell signalling pathways |
2 |
|
cellular immunity |
2 |
|
chromosomal instability - genetics |
2 |
|
cytoskeleton. |
2 |
|
dna-binding proteins - antagonists and inhibitors - drug effects |
2 |
|
enhancer of zeste homolog 2 (ezh2) |
2 |
|
epigenesis, genetic - genetics |
2 |
|
epigenetic |
2 |
|
epigenetic-microrna regulatory circuit |
2 |
|
fibrosis - genetics |
2 |
|
hepatitis b virus - metabolism |
2 |
|
liver - cancer - genetic aspects. |
2 |
|
liver -- cancer. |
2 |
|
liver neoplasms - genetics - virology |
2 |
|
m6am |
2 |
|
micrornas - genetics - pharmacology |
2 |
|
neuroblastoma |
2 |
|
pcf11 |
2 |
|
polycomb group proteins |
2 |
|
premature transcription termination |
2 |
|
signal transduction - genetics |
2 |
|
akr1d1 |
1 |
|
antitumor immunity |
1 |
|
bile acids |
1 |
|
epi-transcriptome |
1 |
|
microbiota |
1 |
|
n6-methyladenosine |
1 |
|
nk cell |
1 |
|
rna epigenetics |
1 |
